Top Industry Leaders in the Insulin Delivery Devices Market
Latest Insulin Delivery Devices Companies Update:
Abbott Recently reported strong performance across all segments, indicating potential market recovery after challenging years (MedTech Dive).
Medtronic Acquired EOFlow in 2022, strengthening their insulin pump portfolio and advancing research in diabetes management. They also received FDA approval for the MiniMed 780G system with automated corrections in April 2023.
Novo Nordisk Launched the first smart insulin pens, NovoPen 6 and NovoPen Echo Plus, in the UK in 2023, marking their entry into the connected insulin pen market.
Insulet Corporation Received FDA approval for their Omnipod® 5 Automated Insulin Delivery System in January 2022, offering a tubeless option for children and adults with Type 1 diabetes.
Dexcom Plans to launch a new CGM this summer for people who don't take insulin, potentially expanding their reach beyond the diabetes market (MedTech Dive).
List of Insulin Delivery Devices Key companies in the market
- Becton, Dickinson and Company
- Novo Nordisk A/S
- Medtronic PLC
- Sanofi
- Eli Lilly
- Johnson and Johnson
- Tandem Diabetes Care Inc.
- Biocon Limited
- Hoffmann-La Roche
- Braun Melsungen AG